Cargando…
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
SIMPLE SUMMARY: Inflammation has been acknowledged as one of the causes of increased cancer risk. Among the pro-inflammatory mediators, tumor necrosis factor alpha (TNFα) has been identified as an important player in cancer progression and metastasis. On the other hand, TNFα has a central role in pr...
Autores principales: | Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia, Elizalde, Patricia Virginia, Schillaci, Roxana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985780/ https://www.ncbi.nlm.nih.gov/pubmed/33540543 http://dx.doi.org/10.3390/cancers13030564 |
Ejemplares similares
-
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020) -
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
por: Bruni, Sofia, et al.
Publicado: (2023) -
Emerging Targeted Therapies for HER2-Positive Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2023) -
ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022) -
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
por: Izzo, Franco, et al.
Publicado: (2014)